Human antithrombin III, DNA sequences therefor, expression vehicles and cloning vectors containing such sequences and cell cultures transformed thereby, a process for expressing human antithrombin III, and pharmaceutical compositions comprising it.

摘要

Human antithrombin III, and aspects concerning its preparation via recombinant DNA technology, form the basis of this disclosure. The disclosed methodology makes possible the preparation of useful quantities of the compound for applications in maintaining the fluidity of blood.